shuttle pharmaceuticals holdings inc a specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy has filed for an initial public offering the company said it intends to list its shares on the nasdaq capital market under the ticker symbol shph the company said it plans to offer 3 million shares at a price between 450 a share and 500 a share the company which doesnt currently have any products approved by the food and drug administration said it seeks to increase cancer cure rates prolong patient survival and improve quality of life when radiation therapy is used as a primary treatment or in combination with surgery chemotherapy and immunotherapy write to will feuer at willfeuerwsjcom